AlphaYouTC
Schedule 13G filing
Tejara Capital Ltd disclosed a 5.3% stake in Cardiol Therapeutics Inc. (CRDL)
Tejara Capital Ltd reported owning 5.3% of Cardiol Therapeutics Inc. (CRDL) (6,382,551 shares) in a Schedule 13G filed Sep 23, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Sep 23, 2026
- Source
- Schedule 13G
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.